This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Institute of Nuclear Energy Research, National Atomic Research Institute. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 522 
1 out of 2 Years Active: 2023
Title: Wei-Lin Lo: Innovator in Radiotherapy Medicine
Introduction
Wei-Lin Lo is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of radiotherapy medicine, particularly in the diagnosis and treatment of prostate cancer. With a total of 2 patents, his work showcases innovative approaches to medical treatment.
Latest Patents
Wei-Lin Lo's latest patents include a groundbreaking invention related to PSMA targeted radiotherapy medicine and its preparation method. This invention features a novel precursor designed for radioisotope labeling with ligands that specifically bind to prostate-specific membrane antigen (PSMA). This technology is aimed at enhancing prostate cancer diagnosis and treatment. The pharmacophore of a PSMA inhibitor is composed of three molecules: glutamic acid, urea, and lysine, which are linked by three variable linkers based on the pharmacological activity of the PSMA inhibitor. This allows for labeling with radioactive nuclei such as Ga-67, Ga-68, In-111, Lu-177, Cu-64, or Y-90, facilitating imaging analysis of human tumor models of prostate cancer and serving as a PSMA-targeted radioligand therapy.
Another significant patent involves a compound or its salt targeting fibroblast activation protein. This patent details the preparation methods and uses of the compound represented by the formula (I) D-R1-R2-A-R', or its salt, emphasizing its potential applications in medical treatments.
Career Highlights
Wei-Lin Lo has worked with esteemed organizations such as the Institute of Nuclear Energy Research and the National Atomic Research Institute. His experience in these institutions has contributed to his expertise in the field of nuclear medicine and radiotherapy.
Collaborations
Throughout his career, Wei-Lin Lo has collaborated with notable colleagues, including Sheng-Nan Lo and Shih-Ying Lee. These partnerships have fostered innovation and advancement in his research endeavors.
Conclusion
Wei-Lin Lo's contributions to radiotherapy medicine exemplify the impact of innovative thinking in healthcare. His patents reflect a commitment to improving cancer diagnosis and treatment, showcasing the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile